Jaguar Health Inc Share Price

NASDAQ: JAGX

Small Cap

$1.97

+0.01

(+0.49%)

as on September 16, 2025 at 1:29 am IST

$₹

Jaguar Health Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$1.92
Day's Price Range
$1.99
$1.97
2.54%
Downside
1.02%
Upside
52 Week's Low
52 Week's High
$1.16
52-Week Price Range
$35.25
$1.97
40.97%
Downside
1689.34%
Upside

Jaguar Health Inc share price movements today

Previous Close: $1.96
Open: $1.99
Volume: 222.3K
Day's Low - High: $1.92 - $1.99
52 Week Low - High: $1.16 - $35.25

Jaguar Health Inc Historical Returns

1 Month Return: -6.67 %
3 Month Return: -43.84 %
1 Year Return: -92.87 %
3 Year Return: -99.99 %
5 Year Return: -100 %

Jaguar Health Inc Stock Fundamentals & Key Indicators

Check Jaguar Health Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.3M

EPS (TTM)

-23.81

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.05

Industry PE ratio

P/B Ratio

0.0522

PEG Ratio

-0.02

EBITDA

-30.9M

Revenue (TTM)

11.8M

Profit Margin

0.00%

Return On Equity TTM

-319.25%

Jaguar Health Inc Stock Valuation

Track how Jaguar Health Inc P/E has moved over time to understand its valuation trends.

Jaguar Health Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 15, 2025

Industry (0.00x)

September 15, 2025

Today (0.05x)

September 15, 2025

Highest (-0.12x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.05x

Jaguar Health Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jaguar Health Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Jaguar Health Inc	BUY	$4.3M	-100%	0.05	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Jaguar Health Inc Stock including INR - Dollar returns

The Jaguar Health Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Jaguar Health Inc investment value today

Current value as on today

₹12,149

Returns

₹87,851

(-87.85%)

Returns from Jaguar Health Inc Stock

₹92,836 (-92.84%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Jaguar Health Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Jaguar Health Inc. Average target price of $28

Jaguar Health Inc Share Price Target

Get share price movements and forecasts by analysts on Jaguar Health Inc.

What analysts predicted

92.96%UPSIDE

Target Price

$28

Current Price

$1.97

Analyzed by

7 Analysts

Target

$28.00

Jaguar Health Inc target price $28, a slight upside of 92.96% compared to current price of $1.97. According to 7 analysts rating.

Jaguar Health Inc Stock's Interest Amongst Investors

Search interest for Jaguar Health Inc Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-32% versus previous 30 day period

Jaguar Health Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	3	1	2	2	2	2	3	3	2	2
Gross Profit	2	1	2	2	1	2	2	2	1	2
Operating Income	-6	-9	-8	-8	-8	-7	-7	-8	-9	-8
EBITDA	-4	-9	-7	-6	-8	-6	-6	-15	-9	-7
Interest Expense	2	2	3	0	0	0	0	-	0	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-12	-12	-7	-9	-9	-10	-10	-10	-10
Income Tax Expense	0	0	0	0	0	0	0	-	0	-
Net Income	-7	-12	-12	-7	-9	-9	-9	-9	-10	-10
Net Profit Margin	-226.38%	-618.76%	-454.04%	-276.50%	-392.43%	-348.84%	-317.05%	-282.70%	-481.99%	-349.35%

Jaguar Health Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	4	4	5	9	4	11	9	11
Gross Profit	0	0	3	1	1	6	2	9	7	9
Operating Income	-12	-13	-34	-30	-24	-21	-39	-34	-34	-30
EBITDA	-12	-13	-11	-27	-30	-28	-42	-33	-33	-36
Interest Expense	3	0	1	2	5	2	8	12	6	0
Depreciation	-	-	0	1	1	2	1	2	2	2
Income Before Tax	-16	-14	-35	-32	-38	-33	-52	-48	-41	-39
Income Tax Expense	3	1	-13	-1	0	2	7	0	0	0
Net Income	-16	-14	-21	-32	-38	-36	-60	-47	-41	-38
Net Profit Margin	-6305.24%	-10410.87%	-503.73%	-727.92%	-667.32%	-392.02%	-1389.87%	-396.91%	-423.11%	-329.30%

Jaguar Health Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-12	-7	-9	-9	-9	-10	-9	-10	-10
Operating Cash Flow	-9	-6	-	-7	-8	-6	-7	-7	-6
Investing Cash Flow	6	0	-	0	0	-	-	0	-
Financing Cash Flow	3	1	-	12	12	3	2	4	2
Change in Cash	-5	-5	-	5	4	-2	-5	-2	-3

Jaguar Health Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-14	-21	-32	-38	-33	-52	-49	-41	-39
Operating Cash Flow	-14	-9	-22	-20	-15	-34	-33	-33	-29
Investing Cash Flow	2	-1	0	0	0	0	-1	1	0
Financing Cash Flow	5	10	24	21	19	43	23	34	31
Change in Cash	-6	0	1	1	4	8	-11	1	1

Global Institutional Holdings in Jaguar Health Inc

Funds	Holdings
UBS Group AG	0.33%
Royal Bank of Canada	0.05%
SBI Securities Co Ltd	0%
Morgan Stanley - Brokerage Accounts	0%
BlackRock Inc	0%

See all

Insights on Jaguar Health Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -10.46M → -10.40M (in $), with an average increase of 0.6% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.17M → 2.97M (in $), with an average increase of 27.1% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 168.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 223.5%
NEGATIVE IMPACT
Price Dip
In the last 3 months, JAGX stock has moved down by -43.8%

About Jaguar Health Inc

jaguar health, inc. is a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. our wholly-owned subsidiary, napo pharmaceuticals, inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. our mytesi® (crofelemer) product is approved by the u.s. fda for the symptomatic relief of noninfectious diarrhea in adults with hiv/aids on antiretroviral therapy. canalevia™ is our lead animal prescription drug candidate, intended for treatment of various forms of diarrhea in dogs. equilevia™ is jaguar’s non-prescription product for total gut health in equine athletes. to read our full social media policy, please visit https://jaguar.health/social-media-policy/

Organisation	Jaguar Health Inc
Headquarters	200 Pine Street, San Francisco, CA, United States, 94104
Industry	Health Technology
CEO	Ms. Lisa A. Conte
E-voting on shares	Click here to vote

Key Management of Jaguar Health Inc

Name	Title
Ms. Lisa A. Conte	Founder, CEO, President & Director
Mr. Jonathan S. Wolin CPA, J.D., M.B.A.	Chief of Staff, Chief Compliance Officer & General Counsel
Dr. Steven R. King Ph.D.	Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary
Dr. Karen J. Brunke Ph.D.	Executive VP of Corporate & Business Development
Mr. Ian H. Wendt M.B.A.	Chief Commercial Officer
Dr. Massimo Radaelli M.B.A., Ph.D.	President of Jaguar International
Dr. Pravin R. Chaturvedi Ph.D.	Chief Scientific Officer & Chair of Scientific Advisory Board
Ms. Carol R. Lizak M.B.A.	Chief Financial Officer
Mr. Peter Hodge	Senior Director of Investor Relations, Business Development & Special Events
Mr. David Sesin Ph.D.	Chief Manufacturing Officer

FAQs

What is Jaguar Health Inc share price today?

Jaguar Health Inc share price today is $1.97 as on September 16, 2025 at 1:29 am IST at the close of the market. Jaguar Health Inc share today touched a day high of $1.99 and a low of $1.92.

What is the 52 week high and 52 week low for Jaguar Health Inc share?

Jaguar Health Inc share touched a 52 week high of $35.25 on September 30, 2024 and a 52 week low of $1.16 on December 23, 2024. Jaguar Health Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $1.97,which is 94.41% down from its 52 week high and 69.42% up from its 52 week low.

What is Jaguar Health Inc's market capitalisation today?

Jaguar Health Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Jaguar Health Inc Stock (JAGX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Jaguar Health Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jaguar Health Inc Shares that will get you 0.7614 shares as per Jaguar Health Inc share price of $1.97 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Jaguar Health Inc Stock (JAGX) from India?

Indian investors can start investing in Jaguar Health Inc (JAGX) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 2:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Jaguar Health Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 2:41 am IST). Based on Jaguar Health Inc share’s latest price of $1.97 as on September 16, 2025 at 1:29 am IST, you will get 5.0761 shares of Jaguar Health Inc. Learn more about fractional shares .

What are the returns that Jaguar Health Inc has given to Indian investors in the last 5 years?

Jaguar Health Inc stock has given -100% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?